Our findings predict that loss-of-function mutations or decreased expression of JPH2 in vascular SMCs would result in excessive arterial contractility and vascular resistance, potentially contributing to systemic hypertension, ischemic stroke, and vascular cognitive impairment and dementia. The gene discussed is JPH2; the disease is Hypertension.